Find the right fit for you - faster
Get tailored insights about working at Remedica in one quick step.
Remedica Snapshot
1 OfficeLocations
To alleviate suffering and improve the quality of human life by providing high quality, safe and efficacious pharmaceuticals and other health and care products, promptly and at a reasonable cost.
Remedica is a pharmaceutical company located in Cyprus with export activities in more than 100 countries.
Originally founded in 1960 by Mr Chris Pattichis as a carbon dioxide manufacturer, it went through various development stages and is now specialising in the development, production and sale of high-quality, safe and efficacious pharmaceutical products for human use. It also markets a number of other health and care products. Its pharmaceutical range consists of a product portfolio of more than 300 generic, branded generic and over-the-counter (OTC) products in more than 100 countries. It offers products from various therapeutic categories including antineoplastic agents, antivirals, cardiovascular, central nervous system agents, gastrointestinal agents, respiratory tract agents, dermatological agents and anti-infective products.
Currently, Remedica has 5 state-of-the-art factories all of which have been routinely inspected and approved by the health authorities of several European Union Member States including those of Cyprus, Germany, United Kingdom and Denmark as well as those of Australia (TGA), Brazil (ANVISA), Japan (PMDA), and many more. Its health and care portfolio contains products such as anti-cancer medicines, an area in which the company specialises, therapies for HIV/AIDS, and drugs to treat conditions of the central nervous and the cardiovascular systems.
Originally founded in 1960 by Mr Chris Pattichis as a carbon dioxide manufacturer, it went through various development stages and is now specialising in the development, production and sale of high-quality, safe and efficacious pharmaceutical products for human use. It also markets a number of other health and care products. Its pharmaceutical range consists of a product portfolio of more than 300 generic, branded generic and over-the-counter (OTC) products in more than 100 countries. It offers products from various therapeutic categories including antineoplastic agents, antivirals, cardiovascular, central nervous system agents, gastrointestinal agents, respiratory tract agents, dermatological agents and anti-infective products.
Currently, Remedica has 5 state-of-the-art factories all of which have been routinely inspected and approved by the health authorities of several European Union Member States including those of Cyprus, Germany, United Kingdom and Denmark as well as those of Australia (TGA), Brazil (ANVISA), Japan (PMDA), and many more. Its health and care portfolio contains products such as anti-cancer medicines, an area in which the company specialises, therapies for HIV/AIDS, and drugs to treat conditions of the central nervous and the cardiovascular systems.
